Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
All content curated by
Published in Dermatology

Journal Scan / Research · March 30, 2019

Effectiveness and Safety of Dupilumab for Atopic Dermatitis Treatment in a Real-Life Setting

Journal of the American Academy of Dermatology

 

Additional Info

Journal of the American Academy of Dermatology
Effectiveness and Safety of Dupilumab for the Treatment of Atopic Dermatitis in a Real-Life French Multicenter Adult Cohort
J Am Acad Dermatol 2019 Feb 27;[EPub Ahead of Print], S Faiz, J Giovannelli, C Podevin, M Jachiet, JD Bouaziz, Z Reguiai, A Nosbaum, A Lasek, MC Ferrier le Bouedec, A Du Thanh, N Raison-Peyron, F Tetart, AB Duval-Modeste, L Misery, F Aubin, A Dompmartin, C Morice, C Droitcourt, A Soria, JP Arnault, J Delaunay, E Mahe, MA Richard, A Schoeffler, JP Lacour, E Begon, A Walter-Lepage, AS Dillies, S Rappelle-Duruy, S Barete, N Bellon, N Beneton, A Valois, S Barbarot, J Seneschal, D Staumont-Salle

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading